Previous 10 | Next 10 |
Summary Last week, Aterian reported preliminary third quarter sales well ahead of expectations but warned on weaker profitability as the company focused on selling through excess inventory. Company to resume its roll-up strategy with the proposed acquisition of a brand in the heal...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Ainos (NASDAQ: AIMD ) stock is gaining on Friday after seeing positive results from hamster trials of its Covid-19 treatment. These trials saw the company measuring the effectiveness of V...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a good-news, bad-news kind of day for Aterian’s (NASDAQ: ATER ) investors. In the good-news column, Aterian is expected to generate tens of millions of dollars in gross proceeds from a share s...
Aterian ( NASDAQ: ATER ) has raised ~$20.2M via registered direct offering of 10,526,368 shares of its common stock and accompanying warrants to purchase 10,526,368 shares of its common stock at a combined offering price of $1.90 (minus $0.0001 for pre-funded warrants). Th...
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the pricing of a registered direct offering of 10,526,368 shares of its common stock (or, in lieu of shares of common stock, pre-funded warrants...
Aterian ( NASDAQ: ATER ) to resume its M&A strategy after its previously announced pause following the disruption of the global ecosystem due to the COVID-19 pandemic. The company intends to purchase the assets of a brand in the health and wellness category as it believes ...
Third Quarter Net Revenue Will Be In The Range of $62 Million To $66 Million Company Intends To Acquire A Health & Wellness Brand NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today an...
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”), today announced that it has granted a restricted stock award with respect to 60,000 shares of common stock to a new employee. This inducement award was granted pursuant to the Aterian 2022 In...
ATER is facing supply chain disruptions that have negatively affected its operations. The company holds a surplus of inventory and is looking to accelerate sales to restock at lower margins. Container ship prices are decreasing and the global supply chain appears to be stabilizing...
NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Popular Science and hOmeLabs are proud to announce the launch of their newly co-branded air purifier . This is the first co-branded product from the partnership between Recurrent and Aterian, which was announced in December 2021 . ...
News, Short Squeeze, Breakout and More Instantly...
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, ...
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company&...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...